Free Shipping for All US and Canadian Orders.
    canadianpharmacyworld ShoppingCart   0   |   Sign Up   Login

    Linzess (Linaclotide)

    TypeDrug NameDosage 
    Linzess72 mcg
    Linzess145 mcg
    Linzess290 mcg


    Buy Linzess 145 mcg
    * The product images are for reference only. Generic equivalents may also be supplied by alternate manufacturers.

    How and Where to Buy Linzess Online?


    CanadianPharmacyWorld.com offers the brand Linzess at unbeatable prices. A valid prescription from your doctor is required. Canadian Pharmacy World carries brand and generic medications from International pharmacies around the world with a valid prescription from your doctor. You can place an order online at www.CanadianPharmacy World.com or call Customer Service at 1866-485-7979. If you have any questions, please refer to FAQ.

    Are there Alternative Names for the Brand and Generic Linzess?


    The brand Linzess capsules come from Canada also called Constella manufactured by Forest Laboratories and from UK also called Constella manufactured by Almirall. There is no generic available for this medication.

    What Dosages and Forms is LInzess available in?


    Linzess is available in the strength of 145 mcg and 290 mcg capsules. Linzess capsules are:
    145mcg – White oblong shaped capsules with the pill imprint “FL 145”;
    290mcg – White oblong shaped capsules with the pill imprint “FL 290”

    What is Linzess used for?


    Linzess (Linaclotide) is a prescription medication that is used to treat chronic constipation or irritable bowel syndrome (IBS) in adults. Linaclotide belongs to the class of medications called guanylate cyclase-C agonists. It works by improving stool texture and it lessens the symptoms such as bloating, abdominal pain or discomfort, straining and feeling of incomplete bowel movements. It also blocks pain signals in the intestines. Linzess should not be given to children under the age of 18. The ususal dose for adults with irritable bowel syndrome is 290 mcg once daily and for chronic constipation is 145 mcg once daily.

    What are the Possible Side Effects of Linzess?


    The common side effects may include diarrhea, gas, headache, stomach pain and swelling or feeling of fullness or pressure in your stomach area. The serious side effects may include:
    • Bright red or black or tarry stools;

    • Hives;

    • Severe or ongoing diarrhea;

    • Severe or unusual stomach pain


    Are there any Precautions or Drug Interactions for Linzess?


    You should not take Linzess if you are allergic to Linaclotide or if you have any other allergies. Before you start taking this medication, talk to your doctor about your medical history and about all the medications you take including OTC and herbal medications. Linzess should not be used during pregnancy unless it is clearly needed. It is unknown if this medication passes into breast milk.

    Linzess Safety and Storage Information


    Linzess capsules should be stored in its original container at room temperature away from light and moisture and out of reach of children and pets. Do not store this medication in the bathroom.

    Blog Post


    The Truth About Who Gets Covered by AHCCCS, Arizona's Medicaid Plan


    Prescriptions dispensed from Canada are dispensed by: Candrug Pharmacy, ID#18985 604-543-8711. Pharmacy Manager: Mohammed Hassan. Pharmacy Address: Unit #202A, 8322-130th Street, Surrey, British Columbia, Canada V3W 8J9.
    This pharmacy is duly licensed in the province of British Columbia, Canada by the College of Pharmacists of BC. If you have any questions or concerns you can contact the college at: 200-1765 West 8th Ave Vancouver, BC V6J 5C6 Canada.
    In addition to dispensing from our affiliated Canadian dispensing pharmacy, we also dispense your medications from international fulfillment centers that are approved by the regulatory bodies from their respective countries. Canadianpharmacyworld.com dispenses medications from fulfillment centers around the world including and not limited to Canada, Singapore, New Zealand, Turkey, Mauritius, India, and United Kingdom.